# A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-52-week-randomized-safety-study-of-a-calcipotriol-betamethasone-dipropionate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Knud Kragballe,Joar Austad,Larry D. Barnes,A. Bibby,M. de la Brassinne,F. Cambazard,Colin Fleming,Heikki Heikkilä,David A. Jolliffe,Jordi Peyrı́,Åke Svensson,J. Toole,Gottfried Wozel |
| Citations | 139 |
| DOI | 10.1111/j.1365-2133.2006.07236.x |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2095476253 |
| PMID | 16704648 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Åke Svensson](https://scholariq.org/researchers/ake-svensson/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.